Research & Development In Brief
This article was originally published in The Tan Sheet
Executive Summary
Low-dose aspirin reduces colorectal cancer
You may also be interested in...
Research & Development In Brief
Daily aspirin lowers the risk of cancers
SupplySide West New Products In Brief
Frutarom sticks probiotic in functional gum: The Israeli flavor and ingredient firm offers an oral-cavity probiotic strain with reported immune-boosting properties, BLIS K12, as an ingredient for functional chewing gums. BLIS K12 promotes ear, nose and throat health and can also help prevent bad breath, Frutarom said in an Oct. 30 release. The company showcased the probiotic at the SupplySide West trade show Nov. 12 in Las Vegas in a 20-mg gum prototype made via a cold-press process by Tab Labs
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.